Celularity CELU
NASDAQ CELU
$1.43 -0.01 (-0.35%)
At close: Sep 10, 2026 · 4:00 PM EDT

Celularity (CELU) Total Liabilities (2018 - 2025)

Celularity's (CELU) quarterly Total Liabilities came in at $145.4 million in Q4 2025, up 17.4% year-over-year from $123.8 million in Q4 2024, and up 8.23% quarter-over-quarter from $134.3 million in Q3 2025.

Analysis

Celularity (CELU) Total Liabilities (2018 - 2025) Analysis & Trends

Celularity (CELU) has reported Total Liabilities for 8 consecutive years, with $145.4 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Total Liabilities rose 17.4% year-over-year to $145.4 million in Q4 2025; TTM through Dec 2025 was $145.4 million, a 17.4% increase from a year earlier, with the FY2025 full-year figure at $145.4 million, up 17.4% from the prior year.
  • Total Liabilities was $145.4 million for Q4 2025 at Celularity, up from $134.3 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $352.1 million in Q3 2021 and troughed at $39.8 million in Q1 2021.
  • A 5-year average of $171.6 million and a median of $134.4 million in 2025 frame the typical range for Total Liabilities.
  • Across the five-year window, Total Liabilities soared 3112.99% in 2021 and plunged 54.18% in 2023, its largest moves.
  • Over 5 years, Total Liabilities stood at $314.7 million in 2021, then plunged by 35.76% to $202.2 million in 2022, then slumped by 49.09% to $102.9 million in 2023, then increased by 20.32% to $123.8 million in 2024, then increased by 17.4% to $145.4 million in 2025.
  • The last three Total Liabilities figures came in at $145.4 million (Q4 2025), $134.3 million (Q3 2025), and $145.8 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn 141.52 Mn
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - 904.22 Mn
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn 179.49 Mn
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn 521.30 Mn
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 661.05 Mn
6 Beam Therapeutics 2.55 Bn 2.55 Bn - 318.91 Mn
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn 126.72 Mn
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn 1.66 Bn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn 132.83 Mn
10 Celularity 36.35 Mn 30.17 Mn -3.27 Mn 145.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 145.39 Mn
Sep 30, 2025 134.33 Mn
Jun 30, 2025 145.78 Mn
Mar 31, 2025 134.38 Mn
Dec 31, 2024 123.85 Mn
Sep 30, 2024 111.56 Mn
Jun 30, 2024 107.68 Mn
Mar 31, 2024 112.57 Mn
Dec 31, 2023 102.93 Mn
Sep 30, 2023 126.95 Mn
Jun 30, 2023 127.92 Mn
Mar 31, 2023 206.79 Mn
Dec 31, 2022 202.17 Mn
Sep 30, 2022 272.88 Mn
Jun 30, 2022 279.19 Mn
Mar 31, 2022 344.30 Mn
Dec 31, 2021 314.71 Mn
Sep 30, 2021 352.07 Mn
Jun 30, 2021 47.45 Mn
Mar 31, 2021 39.77 Mn